$TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Insider Trading Week 11/2018

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in TEVA PHARMACEUTICAL INDUSTRIES LTD in week 11/2018.

<<< Back to the week list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 20 2018TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...Option ExerciseM0.002,35804,717
Mar 20 2018TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...SellS18.382,35843,3402,9745.3 K to 3 K (-44.22 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Stark David MatthewExec. VP Chief Lega ...BuyM0.002,35805,3323 K to 5.3 K (+79.29 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...Option ExerciseM0.001,17902,358
Mar 20 2018TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...SellS17.881,17921,0781,3882.6 K to 1.4 K (-45.93 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...O'Grady Brendan P.EVP, North America ...BuyM0.001,17902,5671.4 K to 2.6 K (+84.94 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...Option ExerciseM0.0087201,746
Mar 20 2018TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...SellS17.894578,1775,7466.2 K to 5.7 K (-7.37 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Nazzi GianfrancoEVP, Growth Markets ...BuyM0.0087206,2035.3 K to 6.2 K (+16.36 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...Option ExerciseM0.0066001,321
Mar 20 2018TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...SellS17.882875,13111,29511.6 K to 11.3 K (-2.48 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...McClellan Michael JamesEVP, Chief Financia ...BuyM0.00660011,58210.9 K to 11.6 K (+6.04 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...Option ExerciseM0.0094301,887
Mar 20 2018TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...SellS17.8894316,8590943 to 0 (-100.00 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Griffin Deborah AChief Accounting Of ...BuyM0.0094309430 to 943
Mar 20 2018TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseM0.002650531
Mar 20 2018TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...Option ExerciseM0.0074701,495
Mar 20 2018TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...SellS17.88911,6277,0517.1 K to 7.1 K (-1.27 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...SellS17.882574,5957,1427.4 K to 7.1 K (-3.47 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...BuyM0.0026507,3997.1 K to 7.4 K (+3.71 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Fridriksdottir HafrunExecutive VP, Globa ...BuyM0.0074707,1346.4 K to 7.1 K (+11.70 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...Option ExerciseM0.001,17902,358
Mar 20 2018TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...SellS17.8857110,2084,4455 K to 4.4 K (-11.38 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Dethlefs SvenEVP Global Marketin ...BuyM0.001,17905,0163.8 K to 5 K (+30.73 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...Option ExerciseM0.001,29702,594
Mar 20 2018TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...SellS17.891,29723,20601.3 K to 0 (-100.00 %)
Mar 20 2018TEVATEVA PHARMACEUTICA ...Daniell RichardExec. VP, European ...BuyM0.001,29701,2970 to 1.3 K